When the Science Bridges the Efficacy and Safety: A Story of Psoronorm Cell Repair Oil

Authors

  • Amruthavalli GV Dr.JRK’s Research and Pharmaceutical Pvt Ltd., 18 &19, Perumal koil street, Kunrathur, Chennai-600 069.
  • Aruna . V Dr.JRK’s Research and Pharmaceutical Pvt Ltd., 18 &19, Perumal koil street, Kunrathur, Chennai-600 069.
  • Gayathri Rajagopal Dr.JRK’s Research and Pharmaceutical Pvt Ltd., 18 &19, Perumal koil street, Kunrathur, Chennai-600 069.

DOI:

https://doi.org/10.37591/rrjomst.v7i1.217

Abstract

Special cosmetic formulations are meant for certain unique benefits that are linked closely with therapeutic effect and hence such formulations require high level of safety considerations. The cosmetic formulations meant for Psoriasis type conditions need to be very safe as the skin of psoriatic patients is very sensitive. More over the Psoriasis is an auto immune disease and the products for these should not have the potential for irritancy. The current study was done on human subjects to check the skin irritancy nature and potential for skin irritancy by skin irritancy test and skin sensitization test. Results are presented in the article.

 

Keywords: Psoriasis, Psoronorm cell repair oil, safety, oil for psoriasis, skin irritation test, skin sensitization test

 

Cite this Article

Amruthavalli G.V, Aruna.V, Gayathri Rajagopal. When Science Bridge Efficacy and Safety –Story of Psoronorm Cell Repair Oil. Research & Reviews: Journal of Medical Science and Technology. 2018; 7(1): 42-44p.

Downloads

Published

2018-05-22

Issue

Vol. 7 No. 1 (2018)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.